DNLI

Denali Therapeutics Inc. [DNLI] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

DNLI Stock Summary

Top DNLI Correlated Resources

DNLI


Top 10 Correlated ETFs

DNLI


Top 10 Correlated Stocks

DNLI


In the News

DNLI Financial details

Company Rating
-
Market Cap
2.54B
Income
-145.22M
Revenue
330.53M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
445
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-21.84
Forward P/E
-
PEG
3.64
P/S
8
P/B
2.43
P/C
-
P/FCF
-7.85
Quick Ratio
15.58
Current Ratio
16.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.04
EPS next Y
-
EPS next Q
-
EPS this Y
-59.23%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-12.53%
Revenue last 5Y
65.43%
Revenue Q/Q
-
EPS Q/Q
19.44%
-
-
-
-
SMA20
-14.98%
SMA50
-44.74%
SMA100
-51.3%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-12%
ROC
-0.15%
Gross Margin
100%
Oper. Margin
-50%
Profit Margin
-37%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
15.45-33.31
52W High
-60.15%
52W Low
-12.33%
RSI
45.15
Rel Volume
1.02
Avg Volume
1.18M
Volume
1.21M
Perf Week
2.26%
Perf Month
-21.21%
Perf Quarter
-50.26%
Perf Half Y
-50.15%
-
-
-
-
Beta
1.331
-
-
Volatility
0.3%, 1.2%
Prev Close
3.22%
Price
13.15
Change
5.12%

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap